Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Health Tip: Don't Use Food as a Reward

-- Food shouldn't be used as a reward to encourage good behavior in children, experts say. Children should learn that food is to fuel the body, not an indulgence. The Academy of Nutrition and Dietetics mentions these alternatives: Having a play date with friends. Getting a treat, such as a set of stickers. Having a special visit with grandparents,...

Posted today in Medical

Inmates Denied Methadone Less Likely to Choose Treatment When Released

Drug addicts forced off methadone maintenance treatment while in prison are much less likely to seek such treatment when they're released than inmates who keep receiving the treatment, a new study finds. Taking inmates off methadone maintenance treatment is widespread policy in U.S. prisons, though the treatment saves lives, reduces drug-seeking behaviors...

Posted yesterday in New Drug Approvals

FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan 550 mg for the treatment of IBS-D in adults. The FDA approval of Xifaxan 550 mg is based on data from three phase 3 studies, TARGET...

Posted 2 days ago in New Drug Approvals

FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

Actavis plc (NYSE: ACT) announced today that Viberzi (eluxadoline) was approved by the Food and Drug Administration (FDA) as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). Viberzi (eluxadoline) has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist, and a...

Posted 2 days ago in Clinical Trials

Pivotal Study Results Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma

Amgen (NASDAQ: AMGN) today announced the publication of primary results from the Phase 3 OPTiM study in the Journal of Clinical Oncology (JCO). The data published in JCO, which were previously presented at the Annual Meetings of the American Society of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated a significantly higher durable response rate...

Posted today in Medical

Health Highlights: May 29, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Boston Scientific Ordered to Pay $100 Million in Transvaginal Mesh Insert Case Medical device maker Boston Scientific has been ordered to pay $100 million to a woman who suffered major complications after having the company's transvaginal mesh inserts...

Posted today in Medical

Excess Weight Linked to Worse Prostate Cancer Prognosis

Radiation therapy for prostate cancer may be less effective for overweight and obese men than for men of normal weight, a new study suggests. Higher rates of prostate cancer relapse, prostate cancer death, and death from other causes were seen for overweight and obese men in this study of more than 1,400 prostate cancer patients. "It isn't the weight...

Posted today in Medical

Health Tip: Protect Your Eyes From Corneal Abrasion

-- A corneal abrasion is the medical term for a scratch on the eye's cornea. The American Academy of Family Physicians says there are steps you can take to protect your eyes from this injury: Wear a pair of protective goggles any time you are near machinery that could send particles into the air. Trim your fingernails short. Keep low-hanging tree...

Posted today in Medical

Rapamune Approved for Rare Lung Disease

Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat a rare, progressive lung disease that mostly affects women of childbearing age. Lymphangioleiomyomatosis (LAM) is characterized by the unusual growth of smooth-muscle cells among lung tissue. This can block normal airflow in the lungs and hinder delivery of oxygen...

Posted today in Medical

Millennials Turning Their Backs on Religion

Millennials -- those born in the 1980s and 1990s -- are the least religious generation of Americans in the last six decades, a new study says. For the study, researchers analyzed data from 11.2 million participants in four national surveys of U.S. teens, aged 13 to 18, conducted between 1966 and 2014. The investigators found that millennials are less...

Read more news...

Recently added consumer and prescribing information: Viberzi, Stiolto Respimat, Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web4)